通过激活血管光滑肌细胞转录因子EB,环素可以预防腹腔大动脉动脉瘤
Haocheng Lu1, Jinjian Sun1, Wenying Liang1
1Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan Medical Center, Ann Arbor.
Circulation
|May 2, 2020
概括
转录因子EB (TFEB) 通过抑制血管光滑肌细胞亡来保护腹腔大动脉瘤 (AAA). 用2-基-β-环氧激活TFEB可能为AAA提供一种新疗法.
科学领域:
- 血管生物学
- 分子医学
- 细胞平衡
背景情况:
- 腹主动脉动脉瘤 (AAA) 是一种危及生命的主动脉疾病,需要有效的药物治疗来防止扩张和破裂.
- 转录因子EB (TFEB) 是细胞过程的关键调节者,包括自和溶酶生物发生,对维持细胞健康至关重要.
研究的目的:
- 研究血管光滑肌细胞 (VSMC) 特定TFEB在AAA发育中的作用.
- 确定TFEB作为AAA治疗的潜在治疗点.
主要方法:
- 在人类和小鼠AAA样本中测量TFEB表达.
- 在VSMC和VSMC选择性Tfeb淘汰小鼠中使用功能损失/增益研究.
- 进行了转录组和功能分析以阐明TFEB的机制.
- 使用小鼠AAA模型来评估TFEB的体内功能和TFEB激活剂的影响.
主要成果:
- 在人类和小鼠的AAA病变中,TFEB表达减少.
- 部分通过上调B细胞淋巴瘤2来抑制VSMC亡.
- 在小鼠模型中,TFEB缺乏加剧了VSMC亡并促进了AAA形成.
- 通过依赖于VSMC的TFEB机制,TFEB激活剂2-基-β-环氧在小鼠中抑制了AAA的进展.
结论:
- TFEB对VSMC细胞亡和AAA的发展起着保护作用.
- TFEB激活是预防和治疗AAA的一个有前途的治疗策略.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.5K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.5K
Regulation of Angiogenesis and Blood Supply
3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K


